2022 National Alzheimer's Summit

2022 National Alzheimer's Summit
The 2022 National Alzheimer's Summit brings together international leaders working to end Alzheimer's disease as we discuss solutions to the most pressing challenges facing our movement. Over the course of two half-days, October 12-13, sessions will cover the latest scientific developments in prevention, early detection, and treatment—with a focus on ensuring more equitable access to innovations for everyone, especially women and people of color, who are disproportionately affected by Alzheimer’s.

Miss a session?

Jump down to Sessions
to watch anything you missed.

100+

Interface blocks to build a beautiful, dynamic website.

43,000+

Customers have launched sites with Medium Rare templates.

30+

Responsive pages included with Ollie, to complete your online presence.
2022 National Alzheimer's Summit

Summit Schedule

1:00–1:15 PM
ET
Now Live!

State of the Movement – George Vradenburg

View Session
George Vradenburg, Chairman, UsAgainstAlzheimer's
1:15–2:10 PM
ET
Now Live!
Town Hall

Drugs in the Pipeline: What’s Next and the Science Behind It

The biology of Alzheimer’s is complex. This session will cover the latest research at the heart of the amyloid hypothesis, how each new drug in this class is different, and what other innovative solutions are being explored. Key Question: What should all of Us know as we face a disease with very limited treatment options today?

View Session
2:30–3:15 PM
ET
Now Live!
Town Hall

Prioritizing Early Detection: What’s Needed, What’s Working, and How We Can Ensure Everyone Has Access

Although Black and Latino older adults are more likely to develop Alzheimer’s and dementia, diagnoses are more likely to be missed or delayed for people in these groups. Lumping together all people of color with a “one size fits all” approach is not the solution. These disparities stem from a complex set of factors including systemic racism, historic marginalization, cost, and more. Key Question: How can all of Us drive brain health awareness, risk reduction, and early detection—especially in Black and Latino communities?

View Session
3:30–4:15 PM
ET
Now Live!
Town Hall

Beyond Contemplating the Challenge of Inclusion in Clinical Trials

Clinical trials have traditionally fallen short when it comes to including people who are truly representative of the Alzheimer’s population. Recently successful efforts, however, are dispelling myths about the inclusion challenge. For example, among the 389 participants in the Evaluating Minority Patients with Actemra (EMPACTA) study approximately 84% were from Black, Hispanic, Native American, and other historically underrepresented groups. Key Question: What strategies successfully recruit, enroll, and retain participants who represent all of Us, especially those disproportionately affected?

View Session
4:15–4:45 PM
ET
Now Live!
Fireside Chat

Fireside chat with U.S. Representative Anna G. Eshoo and George Vradenburg

View Session
4:45–5:00 PM
ET
Now Live!

Day 1 Closing Remarks – Russ Paulsen

View Session
1:00–1:25 PM
ET
Now Live!

Day 2 Summit Kick-off

Rising longevity and the aging of boomers worldwide are radically altering both the demographic landscape and every aspect of our personal, social, financial, and political lives. What gero-science breakthroughs are currently at the tipping point?  How can we ensure that our health spans and brain spans match our life spans? And how can we secure abundant brain health for all, not just the wealthy? Why and how must we stop Alzheimer’s from being the sinkhole of the 21st century—and do it now!

View Session
Featured Speakers
Ken Dychtwald, PhD
Ken Dychtwald, PhD
1:30–2:15 PM
ET
Town Hall
Now Live!

The Lifestyle Prescription: Delaying and Preventing ADRD through Behavior Change

Research is clear that reducing modifiable risk factors such as obesity, physical inactivity, poor nutrition, hypertension, smoking, hearing loss, and loneliness could prevent hundreds of thousands of dementia cases, particularly among Black and Latino people. But scientific evidence isn’t enough to motivate behavior change. Key Question: How do we move from science to systems with strategies and polices that ensure equitable impact for all of Us?

View Session
Featured Speakers
Marc Middleton
Marc Middleton
2:30–3:15 PM
ET
Town Hall
Now Live!

Investments in Innovation: The Path to New Alzheimer’s Treatments

Identifying and investing in innovative, impactful therapies is only possible when leading scientists and entrepreneurs are connected and have access to capital. Leaders of influential global investment organizations with a venture-minded approach to drug discovery will discuss their perspectives, resources, and funding opportunities to support and accelerate Alzheimer’s treatments. Key Question: What new drugs, technologies, and breakthrough innovations might benefit all of Us in the next 10 years, and how do we spark investment?

View Session
Featured Speakers
3:15–3:45 PM
ET
Fireside Chat
Now Live!

Fireside chat with U.S. Senator Susan Collins and George Vradenburg

View Session
Featured Speakers
The Honorable Susan Collins, George Vradenburg
The Honorable Susan Collins, George Vradenburg
3:45–4:00 PM
ET
Now Live!

Summit Closing Remarks – Russ Paulsen

View Session
Featured Speakers
Russ Paulsen
Russ Paulsen
Marc Middleton
Marc Middleton
Founder and CEO, Growing Bolder
Stephanie Monroe
Stephanie Monroe
Director of Equity and Access, UsAgainstAlzheimer's; Executive Director, AfricanAmericansAgainstAlzheimer’s
John Dwyer
John Dwyer
President, Global Alzheimer’s Platform Foundation; Founding Board Member, UsAgainstAlzheimer's
Yaning Wang
Yaning Wang
CEO, Createrna Science and Technology
, PhD
Dennis Selkoe
Dennis Selkoe
Vincent and Stella Coates Professor of Neurologic Diseases, Harvard Medical School; Co-Director, Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital
, MD
Eliezer Masliah
Eliezer Masliah
Director, Division of Neuroscience, National Institute on Aging
, MD
Debra Lappin
Debra Lappin
Senior Policy Consultant, Faegre Drinker Consulting; Senior Strategic Counsel, UsAgainstAlzheimer's
The Honorable Susan Collins
The Honorable Susan Collins
United States Senator, Maine
Ken Dychtwald
Ken Dychtwald
CEO, Age Wave; Psychologist, Gerontologist, Advisor, Filmmaker, Author
, PhD
The Honorable Anna G. Eshoo
The Honorable Anna G. Eshoo
United States Representative, California
Russ Paulsen
Russ Paulsen
Chief Operating Officer, UsAgainstAlzheimer's
George Vradenburg
George Vradenburg
Chairman, UsAgainstAlzheimer's
2022 National Alzheimer's Summit
“ How can we build resiliency against future pandemics to protect the dementia community? ”
— George Vradenburg
Virtual Summit

Featured Speakers

Sponsors

Thank You to Our Sponsors

Premier Sponsors
BiogenEisaiLilly
Platinum Sponsors
Edward JonesGenetech